3/29, 10:11 PM (Source: TeleTrader)
more TeleTrader news

GSK to support making 60M doses of Novavax jab

Novavax, Inc. and GlaxoSmithKline plc (GSK) announced on Monday that they reached an agreement on the manufacturing of 60 million doses of Novavax's coronavirus vaccine candidate.

Under the deal, GSK "will provide 'fill and finish' manufacturing capacity at its Barnard Castle facility in the North East of England" starting from May.

The companies noted that Novavax and the United Kingdom government already reached an agreement on the purchase of 60 million doses of the COVID-19 vaccine candidate, which showed 96.4% efficacy against the original strain of the virus in a Phase 3 trial in the country.

Breaking the News / NP